Making Medicine Incubate Coalition

Everyone wants to make healthy choices. But we don't always have an opportunity to make healthy choices. 
In today’s episode, we speak with Dr. Jerome Adams, Executive Director of Health Equity Initiatives at Purdue University and the 20th Surgeon General of the United States, about the need for proactive accessible health care, the economic burden of inaccessible healthcare, and why people need to know you care, before they care about what you know

As we continue this journey together, we want to hear from you, the listener. Email John@incubatecoalition.org or Ashlyn@incubatecoalition.org what’s top of mind, what story you want to hear, or what you find interesting!
To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.

Investors are logical people. They invest in medicines that they expect will give them a return.
Right now, there’s far too little investment in developing new antibiotics. The pipeline of treatment is thin, but the need is greater than ever.
Enter the AMR Action Fund.
Hear our conversation with Dr. Henry Skinner, Chief Executive Officer at AMR Action Fund about:
The increasing cost of AMR and policy challenges
How to build the pipeline to reach the new antibiotics we need to save millions
Leveraging healthcare innovation for AMR before it’s too late
AMR Action Fund’s first two investments and future outlook 


More information about Henry and today’s topics:
LinkedIn Profile: http://www.linkedin.com/in/henryskinner/
Company Website: https://www.amractionfund.com/ 


As we continue this journey together, we want to hear from you, the listener. Email John@incubatecoalition.org or Ashlyn@incubatecoalition.org what’s top of mind, what story you want to hear, or what you find interesting!
To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.

We’ll be the first to say that the healthcare system is broken, especially in patient access complexity.
However, we see three areas where we can execute actionable change for patients in 2022: intellectual property, mergers and acquisitions, and the FDA’s reauthorization.
In this episode, Coalition Manager and podcast host Ashlyn Roberts interviews John Stanford, Executive Director at Incubate Coalition, about opportunities for pro-patient reform.
Join us as we discuss:
A level set of what’s been happening in Washington lately
Why drug pricing issues are still evergreen
3 areas for improvement: IP, M&A, and PDUFA
Shifting the narrative about pro-patient reforms



As we continue this journey together, we want to hear from you, the listener. Email John@incubatecoalition.org or Ashlyn@incubatecoalition.org what’s top of mind, what story you want to hear, or what you find interesting!
To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.
Listening on a desktop & can’t see the links? Just search for Making Medicine in your favorite podcast player.

If we want data and clinical trials that meaningfully represent the population of people who take the drug, we’ll need to do more than just issue guides.
In this episode, we interview returning guest Kirsten Axelsen,Senior Advisor for Charles River Associates, about making medicine more accessible to lower income people and creating a more equitable health system with better data.
Join us as we discuss:
The detrimental effects of price controls on early life stages of drug development
Why a price control on one is a price control on all
The deep concerns about health disparity and equity
How data can address racism, ageism, and poverty in health systems
2022 as the year of the non-COVID vaccine



Check out these resources we mentioned:
Report referenced at 1:16 here and here.
Build Back Better Act 



As we continue this journey together, we want to hear from you, the listener. Email John@incubatecoalition.org or Ashlyn@incubatecoalition.org what’s top of mind, what story you want to hear, or what you find interesting!
To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.
Listening on a desktop & can’t see the links? Just search for Making Medicine in your favorite podcast player.

Drug development is a relay race because you pass the baton to the next runner who will take it to the next level. You are proud to have made it onto the stairs at the end of the race not as an individual but as a huge team of experts of subsequent talents.
In this episode we interview Johannes Fruehauf, Founder and CEO at LabCentral/BioLabs, about how the relay race metaphor shapes our understanding of drug development and why we need knowledgeable capital to forge ahead.
Join us as we discuss:
Solving challenges that face scaling entrepreneurs
The stages of the drug development relay race
Investing in a drug development ecosystem that diversifies talent
The need for investors who understand pharmaceutical startup proposals  


As we continue this journey together, we want to hear from you, the listener. Email John@incubatecoalition.org or Ashlyn@incubatecoalition.org what’s top of mind, what story you want to hear, or what you find interesting!
To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.
Listening on a desktop & can’t see the links? Just search for Making Medicine in your favorite podcast player.

Drug policy debate today is like a wetland. It’s the heart of the ecosystem that has to be preserved at all costs — or else we lose the wetlands, the shore, everything.
In this episode, we interview Jean-Francois Formela, Partner at Atlas Venture, about what brought him to Washington and his views on the government’s role in drug development.
Join us as we discuss:
Where are we going in drug development
The role of new modalities
Investor goals: great science, great company, good return
A future in which governments enable the biopharmaceutical community to cure disease



To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.
Listening on a desktop & can’t see the links? Just search for Making Medicine in your favorite podcast player.